Bicara Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 34.9% | 34.9% | -22.2% |
| FY2024 | -13.8% | -13.8% | -13.3% |
| FY2025 | -34.4% | -34.4% | -32.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | 34.9% | 34.9% | -22.2% |
| FY2024 | -13.8% | -13.8% | -13.3% |
| FY2025 | -34.4% | -34.4% | -32.0% |